Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study

Siragusa, Sergio, Malato, Alessandra, Anastasio, Raffaela, Cigna, Valeria, Milio, Glauco, Amato, Corrado, Bellisi, Mario, Attanzio, Maria Teresa, Cormaci, Oreste, Pellegrino, Massimo, Dolce, Alberto, Casuccio, Alessandra, Bajardi, Guido, Mariani, Guglielmo · 2008 · Blood

Abstract

Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for evaluating the optimal duration of oral anticoagulant treatment (OAT). Patients with a first episode of deep vein thrombosis, treated with OAT for 3 months, were managed according to RVT findings. Those with RVT were randomized to either stop or continue anticoagulants for 9 additional months, whereas in those without RVT, OAT was stopped. Outcomes were recurrent venous thromboembolism and/or major bleeding. Residual thrombosis was detected in 180 (69.8%) of 258 patients; recurrent events occurred in 27.2% of those who discontinued (25/92; 15.2% person-years) and 19.3% of those who continued OAT (17/88; 10.1% person-years). The relative adjusted hazard ratio (HR) was 1.58 (95% confidence interval [CI], 0.85-2.93; P = .145). Of the 78 (30.2%) patients without RVT, only 1 (1.3%; 0.63% person-years) had a recurrence. The adjusted HR of patients with RVT versus those without was 24.9 (95% CI, 3.4-183.6; P = .002). One major bleeding event (1.1%; 0.53% person-years) occurred in patients who stopped and 2 occurred (2.3%; 1.1% person-years) in those who continued OAT. Absence of RVT identifies a group of patients at very low risk for recurrent thrombosis who can safely stop OAT. This trial was registered at http://www.ClinicalTrials.gov as no. NCT00438230.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2008-01-131656

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 11

  1. Schulman, 1995, A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism., N Engl J Med, 332, 1661, 10.1056/NEJM199506223322501 · DOI · Paper page
  2. Kearon, 1999, A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism., N Engl J Med, 340, 901, 10.1056/NEJM199903253401201 · DOI · Paper page
  3. Pinede, 2001, Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis., Circulation, 103, 2453, 10.1161/01.CIR.103.20.2453 · DOI · Paper page
  4. Heit, 2000, Predictors of recurrence after deep vein thrombosis and pulmonary embolism. A population-based cohort study., Arch Intern Med, 160, 761, 10.1001/archinte.160.6.761 · DOI · Paper page
  5. Palareti, 1996, Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT): Italian Study on Complications of Oral Anticoagulant Therapy., Lancet, 348, 423, 10.1016/S0140-6736(96)01109-9 · DOI · Paper page
  6. Piovella, 2002, Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis., Haematologica, 87, 515
  7. Prandoni, 2002, Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism., Ann Intern Med, 137, 955, 10.7326/0003-4819-137-12-200212170-00008 · DOI · Paper page
  8. Prandoni, 2002, The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis., Thromb Haemost, 88, 402, 10.1055/s-0037-1613229 · DOI
  9. Fedullo, 2003, The evaluation of suspected pulmonary embolism., N Engl J Med, 349, 1247, 10.1056/NEJMcp035442 · DOI · Paper page
  10. Kearon, 2003, Diagnosis of pulmonary embolism., Can Med Assoc J, 168, 183
  11. Agnelli, 2001, Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis: Warfarin Optimal Duration Italian Trial Investigators., N Engl J Med, 345, 165, 10.1056/NEJM200107193450302 · DOI · Paper page

Cited by

See all 196

Metadata

Authors
Siragusa, S., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M., Attanzio, M. T., Cormaci, O., Pellegrino, M., Dolce, A., Casuccio, A., Bajardi, G., & Mariani, G.
Venue
Blood
Published
2008-08-01
Volume
112
Issue
3
Pages
511-515
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1997534178
Cited by
196
References
4
FWCI
9.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. https://app.cochat.ai/papers/10.1182/blood-2008-01-131656
The paper
Siragusa, S., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M., Attanzio, M. T., Cormaci, O., Pellegrino, M., Dolce, A., Casuccio, A., Bajardi, G., & Mariani, G. (2008). Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood. https://doi.org/10.1182/blood-2008-01-131656

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.